>>Back
Expect a bump to GSK's Human Genome offer, but not a big one
  • Publisher：
  • Publication：2012/6/13
Investors and analysts alike expect GlaxoSmithKline ($GSK) to increase its bid for Human Genome Sciences ($HGSI), but not by much, Bloomberg reports. GSK probably will raise its $2.6 billion, $13-per-share offer by $1 to $2 per share, they said.

Excipients

PHEXCOM is a registered trademark of Shanghai Phexcom Information Technology Co.,Ltd. Copyright 2009-2025 Shanghai Phexcom Information Technology Co.,Ltd. All rights reserved.
版权所有:辅料网 ICP备案编号： 沪ICP备09013362号-1